Gain of interaction of ALS-linked G93A superoxide dismutase with cytosolic malate dehydrogenase

Neurobiology of Disease

Volumn 32, Issue 1, 2008, Pages 133-141

  Mali, Yael ^a   Zisapels, Nava ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

ALS; Amyotrophic Lateral Sclerosis; FRET; Malate dehydrogenase; Neurons; Protein interactions; SOD1

Indexed keywords

ASPARTIC ACID; COPPER ZINC SUPEROXIDE DISMUTASE; LACTIC ACID; MALATE DEHYDROGENASE; MALIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOSOL; DRUG TARGETING; ENZYME ACTIVITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE MUTATION; GLYCOLYSIS; MITOCHONDRION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASPARTIC ACID; CELL LINE; CYTOSOL; HUMANS; MALATE DEHYDROGENASE; MALATES; MICE; MICE, INBRED C57BL; NEURONS; SUPEROXIDE DISMUTASE;

EID: 51349139121     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.06.010     Document Type: Article

References (34)

1. Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid. Redox. Signal 7 (2005) 1140-1149
2. Barron J.T., Gu L., and Parrillo J.E. Malate-aspartate shuttle, cytoplasmic NADH redox potential, and energetics in vascular smooth muscle. J. Mol. Cell. Cardiol. 30 (1998) 1571-1579
3. Beal M.F. Mitochondria and the pathogenesis of ALS. Brain 123 Pt 7 (2000) 1291-1292
4. Bendotti C., and Carri M.T. Lessons from models of SOD1-linked familial ALS. Trends. Mol. Med. 10 (2004) 393-400
5. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27 (2004) 723-749
6. Bubis M., and Zisapel N. A role for NAD+ and cADP-ribose in melatonin signal transduction. Mol. Cell. Endocrinol. 137 (1998) 59-67
7. Carri M.T., Ferri A., Battistoni A., Famhy L., Gabbianelli R., Poccia F., and Rotilio G. Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett. 414 (1997) 365-368
8. Cashman N.R., Durham H.D., Blusztajn J.K., Oda K., Tabira T., Shaw I.T., Dahrouge S., and Antel J.P. Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 194 (1992) 209-221
9. Chan F.K. Monitoring molecular interactions in living cells using flow cytometric analysis of fluorescence resonance energy transfer. Methods Mol. Biol. 261 (2004) 371-382
10. Desport J.C., Preux P.M., Magy L., Boirie Y., Vallat J.M., Beaufrere B., and Couratier P. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am. J. Clin. Nutr. 74 (2001) 328-334
11. Desport J.C., Torny F., Lacoste M., Preux P.M., and Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener. Dis. 2 (2005) 202-207
12. Dunckley T., Huentelman M.J., Craig D.W., Pearson J.V., Szelinger S., Joshipura K., Halperin R.F., Stamper C., Jensen K.R., Letizia D., Hesterlee S.E., Pestronk A., Levine T., Bertorini T., Graves M.C., Mozaffar T., Jackson C.E., Bosch P., McVey A., Dick A., Barohn R., Lomen-Hoerth C., Rosenfeld J., O'Connor D.T., Zhang K., Crook R., Ryberg H., Hutton M., Katz J., Simpson E.P., Mitsumoto H., Bowser R., Miller R.G., Appel S.H., and Stephan D.A. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N. Engl. J. Med. 357 (2007) 775-788
13. Fergani A., Oudart H., Gonzalez de Aguilar J.L., Fricker B., Rene F., Hocquette J.F., Meininger V., Dupuis L., and Loeffler J.P. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J. Lipid. Ress. (2007)
14. Ferraiuolo L., Heath P.R., Holden H., Kasher P., Kirby J., and Shaw P.J. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J. Neurosci. 27 (2007) 9201-9219
15. Ganesan S., Rohde G., Eckermann K., Sroka K., Schaefer M.K., Dohm C.P., Kermer P., Haase G., Wouters F., Bähr M., and Weishaupt J.H. Mutant SOD1 detoxification mechanisms in intact single cells. Cell. Death. Differ. 15 2 (2008) 312-321
16. Hu R., Jin H., Zhou S., Yang P., and Li X. Proteomic analysis of hypoxia-induced responses in the syncytialization of human placental cell line BeWo. Placenta 28 (2007) 399-407
17. Kaal E.C., Vlug A.S., Versleijen M.W., Kuilman M., Joosten E.A., and Bar P.R. Chronic mitochondrial inhibition induces selective motoneuron death in vitro: a new model for amyotrophic lateral sclerosis. J. Neurochem. 74 (2000) 1158-1165
18. Kasarskis E.J., and Neville H.E. Management of ALS: nutritional care. Neurology 47 (1996) S118-S120
19. Kruman I.I., Pedersen W.A., Springer J.E., and Mattson M.P. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp. Neurol. 160 (1999) 28-39
20. Lederer C.W., Torrisi A., Pantelidou M., Santama N., and Cavallaro S. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC. Genomics 8 (2007) 26
21. Liu J., Lillo C., Jonsson P.A., Vande Velde C., Ward C.M., Miller T.M., Subramaniam J.R., Rothstein J.D., Marklund S., Andersen P.M., Brännström T., Gredal O., Wong P.C., Williams D.S., and Cleveland D.W. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 8 (43)1 (2004) 5-17
22. McKenna M.C., Waagepetersen H.S., Schousboe A., and Sonnewald U. Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools. Biochem. Pharmacol. 71 (2006) 399-407
23. Menzies F.M., Cookson M.R., Taylor R.W., Turnbull D.M., Chrzanowska-Lightowlers Z.M., Dong L., Figlewicz D.A., and Shaw P.J. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain 125 (2002) 1522-1533
24. Ramos M., del Arco A., Pardo B., Martinez-Serrano A., Martinez-Morales J.R., Kobayashi K., Yasuda T., Bogonez E., Bovolenta P., Saheki T., and Satrustegui J. Developmental changes in the Ca2+-regulated mitochondrial aspartate-glutamate carrier aralar1 in brain and prominent expression in the spinal cord. Brain. Res. Dev. Brain. Res. 143 (2003) 33-46
25. Rizzardini M., Mangolini A., Lupi M., Ubezio P., Bendotti C., and Cantoni L. Low levels of ALS-linked Cu/Zn superoxide dismutase increase the production of reactive oxygen species and cause mitochondrial damage and death in motor neuron-like cells. J. Neurol. Sci. 232 (2005) 95-103
26. Rothstein J.D., Martin L.J., and Kuncl R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326 22 (1992) 1464-1468
27. Sau D., De Biasi S., Vitellaro-Zuccarello L., Riso P., Guarnieri S., Porrini M., Simeoni S., Crippa V., Onesto E., Palazzolo I., Rusmini P., Bolzoni E., Bendotti C., and Poletti A. Mutation of SOD1 in ALS: a gain of a loss of function. Hum. Mol. Genet. 16 (2007) 1604-1618
28. Shinder G.A., Lacourse M.C., Minotti S., and Durham H.D. Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J. Biol. Chem. 276 (2001) 12791-12796
29. Vande Velde C., Miller T.M., Cashman N.R., and Cleveland D.W. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc. Natl. Acad. Sci. U. S. A. 11;105 10 (2008) 4022-4027
30. Van Westerlaak M.G., Joosten E.A., Gribnau A.A., Cools A.R., and Bar P.R. Differential cortico-motoneuron vulnerability after chronic mitochondrial inhibition in vitro and the role of glutamate receptors. Brain. Res. 922 (2001) 243-249
31. Vijayvergiya C., Beal M.F., Buck J., and Manfredi G. Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J. Neurosci. 9; 25 10 (2005) 2463-2470
32. Zhang F., Strom A.L., Fukada K., Lee S., Hayward L.J., and Zhu H. Interaction between familial ALS-linked SOD1 mutants and the dynein complex: implications of retrograde axonal transport in ALS. J. Biol. Chem. (2007)
33. Zheng J., Varnum M.D., and Zagotta W.N. Disruption of an intersubunit interaction underlies Ca2+-calmodulin modulation of cyclic nucleotide-gated channels. J. Neurosci. 23 (2003) 8167-8175
34. Zhou L., Stanley W.C., Saidel G.M., Yu X., and Cabrera M.E. Regulation of lactate production at the onset of ischaemia is independent of mitochondrial NADH/NAD+: insights from in silico studies. J. Physiol. 569 (2005) 925-937